Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139264 · ClinicalTrials.gov registry record
Glucose, Activity, Diet, & Sleep Assessment Study
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 14
- Enrollment target
NCT05139264: Completed study, sponsored by Columbia University.
NCT05139264 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05139264 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
GLADS is a cross-sectional, observational study assessing free-living diet, physical activity, sleep, and glucose profile over a 2-week period in healthy adult men and women.
Primary Outcome
Mean, fasting, post-prandial measured by continuous glucose monitoring
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2022-02-01 |
What the finished NCT05139264 record still lists
NCT05139264 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT05139264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05139264 about?
NCT05139264 is a clinical study titled "Glucose, Activity, Diet, & Sleep Assessment Study". GLADS is a cross-sectional, observational study assessing free-living diet, physical activity, sleep, and glucose profile over a 2-week period in healthy adult men and women.
What is the current status of trial NCT05139264?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2021-05-03. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT05139264?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT05139264?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy